Matthew DurhamOmnidynamic Marketing
Suma Ramadas, PhDMedical Affairs
Liz KaneImpactful Strategy
Amy GilesIncreasing Engagement
Stacey GandlerBrand Nourishment
Daniel SontupeMarket Access
Matt TurnerPatient Affordability
Bud BilanichSuccess Coach
Paul TheisenPatient Acquisition
Joey CohenMedication Adherence
Pat PurcellMeeting Engagement
Frank BurrellScientific Storytelling
David LinetskyPoint-of-Care Marketing
Brenda SnowAuthentic Patient Voice
ZEJULA is the #1 PARP inhibitor for women with ovarian cancer in the U.S.2017 ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email